Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997109 · ClinicalTrials.gov registry record · NA

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

A NA study of Cerebral Palsy, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
267
Enrollment target
4
Study locations

NCT04997109 is a NA study of Cerebral Palsy that is actively recruiting participants, run by Emory University. The registered enrollment target is 267 participants, above the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (18% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997109, a NA study of Cerebral Palsy, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
267 participants
Enrollment target
4
Study locations

Study Summary

This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • OTHER APPLES-tele
  • BEHAVIORAL Parent-centered Approach (PCA) Support Intervention

Study Locations (4)

Georgia

  • Emory University - Atlanta

Maryland

  • Kennedy Krieger Institute - Baltimore

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Utah

  • The University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 267 participants
Start Date 2022-02-23
Est. Completion 2027-02-28
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04997109

The ClinicalTrials.gov registry entry for NCT04997109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (18% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.

NCT04997109 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Maryland, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04997109 about?

NCT04997109 is a clinical study titled "Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy". This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.

What is the current status of trial NCT04997109?

This trial is currently recruiting. It is a NA study. The enrollment target is 267 participants. The study started on 2022-02-23. Estimated completion is 2027-02-28.

What conditions does trial NCT04997109 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT04997109?

The interventions under investigation include: Standard of Care (BEHAVIORAL), APPLES-tele (OTHER), Parent-centered Approach (PCA) Support Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04997109?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04997109 being conducted?

This trial has 4 study locations across Georgia, Maryland, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.